FNBT
KERX

FineMark National Bank & Trust’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

FineMark National Bank & Trust’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-846
Closed -$8K – 1610
2015
Q2 		$8K Hold
846
– – ﹤0.01% 1049
2015
Q1 		$11K Hold
846
– – ﹤0.01% 993
2014
Q4 		$12K Hold
846
– – ﹤0.01% 997
2014
Q3 		$12K Hold
846
– – ﹤0.01% 987
2014
Q2 		$13K Hold
846
– – ﹤0.01% 988
2014
Q1 		$14K Buy
+846
New +$12.8K ﹤0.01% 983

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

FineMark National Bank & Trust's KERX Position: Q3 2015 in Review

FineMark National Bank & Trust sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2015, closing a stake of 846 shares — an estimated $8K sold.

FineMark National Bank & Trust first reported a position in KERX in Q1 2014 and held it in 6 quarters. The position peaked at $14K in Q1 2014. 138 funds tracked by Wall St. Rank hold KERX as of Q3 2015.

  • FineMark National Bank & Trust reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 846 Keryx Biopharmaceuticals Inc shares in Q3 2015, an estimated $8K.
  • FineMark National Bank & Trust first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 6 quarters.
  • FineMark National Bank & Trust's Keryx Biopharmaceuticals Inc position peaked at $14K in Q1 2014.
  • 138 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2015.

Based on FineMark National Bank & Trust's 13F filing for Q3 2015, filed 13 Nov 2015.